Related Experiment Video
Updated: Jul 18, 2026

Procedures for the Identification of SARS-CoV-2 Entry Inhibitors as Potential Antivirals using MLV-Based Pseudoviruses
Published on: February 27, 2026
Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b
Sara Akerström1, Ali Mirazimi, Yee-Joo Tan
1Center for Microbiological Preparedness, Swedish Institute for Infectious Disease Control, SE-171 82 Solna, Sweden.
Abstract:
The severe acute respiratory syndrome coronavirus (SARS CoV) genome has 14 potential open reading frames (ORFs). The first ORF is translated from the full-length genomic mRNA while the remaining ORFs are translated from eight subgeomic RNAs (sgRNAs). In this study, we designed small interference RNAs (siRNAs) targeting sgRNA 2, 3 and 7 and tested their efficiency and specificity in silencing the protein translated from the targeted sgRNA. Our results demonstrated that siRNA 7 could inhibit sgRNA 7, which showed 19/19 nucleotides (nt) matching, and sgRNA 8, which showed 18/19 nt matching; but, it did not inhibit the full-length genomic mRNA which showed 17/19 nt matching. Overall, each of the siRNAs can inhibit the targeted sgRNA without affecting the full-length genomic mRNA or the other sgRNAs that showed mismatch of two or more nt. Thus, siRNA could be designed so as to knockdown the expression of viral protein(s) from a targeted sgRNA during viral infection, thereby allowing the contribution of individual viral proteins to viral infection to be delineated. When Vero E6 cells expressing siRNA 2, 3 or 7 were infected with SARS-CoV, a significant reduction in the yield of progeny virus was observed. Indirect immunofluorescence assays showed that in the infected cells expressing each of the siRNAs, there was aspecific silencing of S, 3a and 7a, respectively, but the expression of nucleocapsid protein was not affected. Thus, our data suggests that the accessory proteins, i.e. 3a and 7a, could play an important role during the replication cycle of the SARS-CoV.
Insights
Small interference RNAs (siRNAs) targeting specific subgenomic RNAs (sgRNAs) of SARS-CoV effectively silenced viral proteins. This approach reduced progeny virus yield and highlighted the role of accessory proteins in viral replication.
Area of Science:
- Virology
- Molecular Biology
- RNA Interference
Background:
- The severe acute respiratory syndrome coronavirus (SARS-CoV) genome contains 14 open reading frames (ORFs).
- Viral proteins are translated from full-length genomic mRNA and eight subgenomic RNAs (sgRNAs).
- Understanding the function of individual viral proteins is crucial for combating SARS-CoV infection.
Purpose of the Study:
- To design and test small interference RNAs (siRNAs) for specific silencing of SARS-CoV sgRNAs.
- To evaluate the efficiency and specificity of siRNAs in inhibiting viral protein expression.
- To investigate the role of SARS-CoV accessory proteins in viral replication.
Main Methods:
- Design of siRNAs targeting sgRNA 2, 3, and 7 of SARS-CoV.
- Testing siRNA efficiency and specificity against viral mRNAs using nucleotide matching criteria.
- Infection of Vero E6 cells with SARS-CoV in the presence of designed siRNAs.
- Quantification of progeny virus yield and analysis of viral protein expression using indirect immunofluorescence assays.
Main Results:
- siRNA 7 specifically inhibited sgRNA 7 (19/19 nt match) and sgRNA 8 (18/19 nt match) without affecting full-length genomic mRNA (17/19 nt match).
- All tested siRNAs effectively inhibited their targeted sgRNAs without affecting other sgRNAs with two or more nucleotide mismatches.
- Infection of Vero E6 cells with SARS-CoV and siRNAs resulted in a significant reduction in progeny virus yield.
- Specific silencing of S, 3a, and 7a proteins was observed, while nucleocapsid protein expression remained unaffected.
Conclusions:
- siRNAs can be effectively designed to knockdown specific viral protein expression from targeted sgRNAs during SARS-CoV infection.
- Accessory proteins 3a and 7a play a significant role in the SARS-CoV replication cycle.
- This study provides a method for delineating the contribution of individual viral proteins to viral infection.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis
Coronavirus

